<DOC>
	<DOCNO>NCT00003888</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining one drug combine chemotherapy radiation therapy may kill tumor cell . It yet know regimen combination chemotherapy effective advanced head neck cancer . PURPOSE : Randomized phase III trial compare effectiveness two regimen combination chemotherapy plus radiation therapy treat patient advanced head neck cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Radiation Therapy Treating Patients With Advanced Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare progression free survival patient locally advance , inoperable squamous cell carcinoma head neck treat cisplatin plus fluorouracil without docetaxel neoadjuvant radiotherapy . II . Compare response rate , response duration , toxicity , local symptom , time disease progression treatment regimens patient population . III . Evaluate quality life patient . OUTLINE : This randomize , multicenter study . Patients stratify accord primary tumor site ( oral cavity v oropharynx v hypopharynx v larynx ) institution . Patients randomize one two treatment arm . Arm I : Patients receive docetaxel IV 1 hour , immediately follow cisplatin IV 1 hour day 1 fluorouracil ( 5-FU ) IV continuous infusion day 1-5 . Arm II : Patients receive cisplatin IV 1 hour day 1 follow 5-FU IV continuous infusion day 1-5 . Treatment continue every 3 week 4 course absence disease progression unacceptable toxicity . Patients receive radiotherapy follow chemotherapy within 3-6 week last course . Radiotherapy administer 5 day week 7 week . Quality life assess treatment , course 2 4 , 6 9 month . Patients follow every 3 month first 2 year every 6 month death . PROJECTED ACCRUAL : A total 348 patient accrue study within 24 month .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically proven locally advanced squamous cell carcinoma head neck Stage III IV without distant metastasis Unresectable Primary tumor site : Oral cavity Oropharynx Hypopharynx Larynx Must least one measurable lesion PATIENT CHARACTERISTICS : Age : 18 70 Performance status : WHO 01 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 2,000/mm3 Platelet count least 100,000/mm3 Hemoglobin least 10 g/dL Hepatic : Bilirubin great upper limit normal ( ULN ) SGOT SGPT great 2.5 time ULN Alkaline phosphatase great 5 time ULN No SGOT SGPT great 1.5 time ULN AND alkaline phosphatase great 2.5 time ULN Renal : Creatinine great 1.4 mg/dL OR Creatinine clearance least 60 mL/min Cardiovascular : At least 6 month since prior myocardial infarction No unstable , treated cardiac disease Pulmonary : At least one year since prior hospitalization chronic obstructive pulmonary disease Neurologic : No neurologic psychiatric disorder ( e.g. , dementia seizure ) No concurrent peripheral neuropathy great grade 1 Other : No active uncontrolled infection No active peptic ulcer No alteration hear At least 5 year since neoplastic disease except curatively treat basal squamous cell skin cancer , carcinoma situ cervix , cancer curatively treat surgery Not pregnant nursing Fertile patient must use effective contraception No psychological , familial , sociological , geographical condition would prevent compliance PRIOR CONCURRENT THERAPY : Biologic therapy : No primary prophylactic colony stimulate factor first course therapy Chemotherapy : No prior concurrent chemotherapy Endocrine therapy : At least 3 week since prior corticosteroid No chronic corticosteroid therapy ( great 3 month ) Radiotherapy : No prior radiotherapy Surgery : No prior surgery cancer Other : At least 30 day since prior treatment clinical trial No concurrent use drug interact fluorouracil ( e.g. , cimetidine , allopurinol , folic acid leucovorin calcium ) No concurrent investigational drug anticancer treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
</DOC>